PDL BIOPHARMA INC's ticker is and the CUSIP is 69329YAF1. A total of 19 filers reported holding PDL BIOPHARMA INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $218,000 | +1.4% | 218,000 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $215,000 | +1.4% | 218,000 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $212,000 | 0.0% | 218,000 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $212,000 | +2.4% | 218,000 | 0.0% | 0.00% | -20.0% |
| Q2 2016 | $207,000 | +18.3% | 218,000 | 0.0% | 0.01% | +25.0% |
| Q4 2015 | $175,000 | -8.9% | 218,000 | 0.0% | 0.00% | -20.0% |
| Q3 2015 | $192,000 | -7.2% | 218,000 | 0.0% | 0.01% | 0.0% |
| Q2 2015 | $207,000 | – | 218,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|